Psyomics secures £1.5m funding to transform mental health diagnosis in the UK
Psyomics Ltd, a UK-based healthtech and University of Cambridge spin-out, has closed a £1.5 million funding round from existing and new investors to bring its mental health assessment and diagnosis platform, Censeo, to market in the UK. University spinout specialists Parkwalk led the round, joined by fellow existing investors Jonathan Milner, Martlet, and Cambridge Enterprise.
Wazoku Extends Its Enterprise Innovation Offering With Jira Integration
Idea management integration with Atlassian’s Jira Cloud allows users to join the dots between innovation and project delivery
Scientific Knowledge Discovery Platform Pioneer, Eagle Genomics, Closes $9M in Scale-Up Funding as Major Brands Home in on the Microbiome Megatrend
The biggest names in food, cosmetics, personal care & ‘agritech’ are looking to Eagle Genomics’ AI-augmented, knowledge discovery platform to distil robust scientific evidence in support of marketing claims that their products have a positive biological impact
Abcam raises $180m through US IPO
Cambridge-based Abcam, which supplies tools globally for life science research, has had a blockbusting response to its IPO on America’s NASDAQ technology exchange.
Jeff Seabright appointed Chair of Xampla
Former Unilever Chief Sustainability Officer and Coca Cola VP, Environment & Water Resources joins Xampla as Chair
Xampla is a Cambridge University spin-out that creates natural alternatives to single-use plastic
Xampla is Britain's first university spin-out to be accredited B-Corp status
Hikma and Arecor expand collaboration with new agreement to develop and commercialise ready-to-administer medicine
Adds ready-to-administer injectable product to companies' existing partnership
Cambridge’s Flusso launches world’s smallest flow sensor
Flusso, a semiconductor business spun-out of the University of Cambridge, has launched what it dubs the world’s smallest flow sensor as part of a complete flow sensing solution for use in high-volume consumer and industrial markets.
Underwater survey robot on target after successful trials
A state-of-the-art underwater survey robot being developed by a collaboration of companies from across the UK is on schedule for completion next spring after a successful first demonstration.
Stemnovate creates rapid diagnostic kit for Covid-19 that solves problems of false positives
Stemnovate has released a £10 rapid diagnostic kit for the Covid-19 virus that it says will overcome the challenges of false results in testing.
Cambridge quartet chosen for elite AI programme
Four Cambridge companies have been hand-picked for an elite UK programme designed to propel scaleups in the Artificial Intelligence sector to potential unicorn status accorded to private companies valued at more than $1 billion.
Axol Bioscience introduces multi-electrode array screening services for human iPSC-derived cells
Axol Bioscience (Axol), a biotechnology company specializing in the use of stem cell technology to manufacture disease-relevant cell-based assay systems to the drug discovery industry, today announced the expansion of its service offering, with the introduction of multi-electrode array (MEA) screening for human induced pluripotent stem cell (hiPSC)-derived cells.
Axol Bioscience Introduces Multi-Electrode Array Screening Services for Human iPSC-Derived Cells
Expansion of Axol Bioscience’s service offering for pre-clinical drug discovery
New services combine the Company’s iPSC-derived human cells and electrophysiological expertise with Axion Biosystems’ Maestro Pro MEA platform
Privitar Expands Executive Leadership Team with Appointment of Steven Totman as Chief Product Officer
Expansion comes at a time of rapid company growth marked with prominent award wins from The Sunday Times, Deloitte and FinTech50
University of Manchester, Sano Genetics to Research Eye Diseases
Sano Genetics and researchers at the University of Manchester in the UK said this week that they will collaborate on a new project to translate genetic eye disease research into clinical applications.
NatWest notes instant payback from adopting Featurespace
NatWest is protecting customers with fraud busting technology from Featurespace in Cambridge.
Monese adopts Thought Machine's core banking platform Vault, to reach millions more customers
Monese to migrate European and UK account holders onto Thought Machine's core banking platform
Thought Machine's modern core banking technology combined with Monese's mobile-first approach will unlock new features and capabilities for millions of customers
GeoSpock announces additional $5.4 million in strategic investment
GeoSpock has announced $5.4m in additional funding to accelerate the development and adoption of the fastest, most scalable database on the market. This strategic investment round brings the total GeoSpock has raised to date to over $32 million.
Playing video games helps stroke recovery
A genius game controller helping stroke patients get back hand and arm movement by playing on the computer is set to start tests in a stroke unit.
Graphene Hall effect sensors are ready for high-radiation applications
Paragraf has demonstrated the capability of its graphene Hall Effect sensors to resist high levels of radiation. The discovery, based on testing from the NPL, proves that ‘unpackaged’ Hall Effect sensors can be employed in high-radiation environments such as space. The project was funded by Innovate UK.
Former HSBC Group COO joins Thought Machine
Cloud native banking tech firm Thought Machine has appointed Andy Maguire as Chair.